The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.

Newsletter Jan 2017

Latest Newsletter with the new members of the Scientific Advisory Committee, the public World RePort data base with funding data from NIH, MRC UK, SIDA, EDCTP and other funders and the Ditect-HAT project on diagnostics for sleeping sickness.

Read more

Eighth EDCTP Forum

We published the highlights of the Eighth EDCTP Forum in Lusaka, Zambia from 6-9 November 2016

Forum abstracts were published in BMJ Global Health

 

 

 

 

 

 

Read more

Call for Experts

Extended till 28 February 2017! Call for Experts in the fields of ‘Implementation research’ or ‘biomedical ethics’ for the Scientific Advisory Committee. This Committtee advises EDCTP on strategy. It is not involved in the review EDCTP calls for proposals.

 

Read more

Latest news

24 March 2017

World TB day 2017: closing the gaps to end tuberculosis

Ending the tuberculosis (TB) epidemic by 2030 is one of the health targets of the Sustainable Development Goals. Although TB…

Read more
20 March 2017

PredictTB project launched: biomarkers to predict TB treatment duration

A new EDCTP-funded project was launched at the Tygerberg Campus of Stellenbosch University in Cape Town, South Africa, on 16…

Read more